جست‌وجوی استاد و پژوهشگر

Claire Morganمشاهده پروفایل

دانشیار

• Cancer Research
• Cancer Drug Discovery
• Genomics
• +۵ مورد دیگر

Claire Morgan is an Associate Professor in Biomedical Sciences at Swansea University Medical School, part of the Faculty of Medicine, Health and Life Sciences. She holds dual roles as Programme Director for the MSc Genomic Medicine and BSc Genetics/Medical Genetics degree schemes. Her research focuses on cancer drug discovery, gene manipulation, and genomic medicine, supported by grants from Cancer Research UK and Welsh Government. She has pioneered Wales’ first NHS-supported Genomic Medicine course and chairs key advisory groups like Genomics Partnership Wales and the Wales Gene Park Strategic Advisory Group. Education: PhD in 2002, followed by postdoctoral research at the MRC Cancer Cell Unit in Cambridge before returning to Swansea in 2004. She has extensive teaching experience across undergraduate and postgraduate programs, emphasizing genetics, cancer genetics, and genomics. She is a Senior Fellow of the Higher Education Academy and actively contributes to academic governance as an external examiner for multiple UK institutions. Research interests span cancer drug development, angiogenesis modulation, and genomic applications in healthcare. Key achievements include establishing a pediatric cancer predisposition service in Wales and advancing bacterial-based RNA interference therapies for solid tumors. Her work integrates clinical, translational, and educational dimensions of biomedical science. Awards include grants totaling over £600K for projects like RNAi-based cancer therapies and spectroscopic technologies for respiratory disease management. Collaborations involve interdisciplinary teams across medicine, engineering, and industry. She supervises PhD/MSc students in topics like biomarker identification, genomic diagnostics, and probiotic cancer therapies. Lab affiliations include the Institute of Life Science 1, where her team explores cutting-edge therapies and diagnostic tools. She advocates for genomic education reforms and chairs initiatives to integrate genomics into Welsh healthcare practice.

Audrey McCrary-Quarlesمشاهده پروفایل

استاد

• Health Disparities
• Cancer Awareness and Prevention
• Alzheimer’s Awareness
• +۳ مورد دیگر

Audrey McCrary-Quarles is a Professor of Health Education in the Health and Physical Education Unit at South Carolina State University (SCSU). She holds certifications as a Certified First Aid and CPR Instructor, Certified Health Education Specialist, Certified Dementia Practitioner, and Quality Matters Certified Peer Reviewer. Her primary role involves teaching undergraduate Health Education courses and graduate courses in Education and Healthcare Management Programs. She advises students within her department and mentors those involved in grant-related projects outside the department. Education: BS in Biology from Emory University MSA in Health Services Administration from Central Michigan University Ph.D. in Education with a Health Education focus from Southern Illinois University Carbondale Research focuses on reducing health disparities among minority groups, cancer awareness, Alzheimer’s prevention, healthy aging, injury prevention, and career awareness in agriculture for minority youth. She has secured federal and state grants addressing issues like breast/prostate cancer awareness, vaccine hesitancy among Black communities, and recruitment for Alzheimer’s research. Her community engagement includes outreach programs and collaborations with other institutions. With 14 years of higher education teaching experience and over 15 years in healthcare, McCrary-Quarles emphasizes holistic health education across all ages, guided by her motto: “You are never too young or too old to learn about ways to enhance your body, mind, and spirit for a healthier life.”

• Biostatistics
• Public Health
• Nutrition Science
• +۴ مورد دیگر

Jaakko Nevalainen is a Professor of Biostatistics and Head of the Health Sciences Unit at the University of Tampere , Faculty of Social Sciences. His work integrates computational methods and statistical theory to address health-related research questions in nutrition, diabetes, prostate cancer, and cardiovascular disease. He leads the LoCard research consortium, developing computational methods to study food consumption and health sustainability. His research has received significant funding from the Academy of Finland and Horizon Europe, resulting in over 160 peer-reviewed publications in top journals like Statistics in Medicine , Diabetologia , and JAMA . Key research areas include biostatistical method development, health economics, and applied epidemiology. His teams collaborate with institutions like the University of Helsinki and participate in population studies such as ProScreen (prostate cancer screening) and DIPP (type 1 diabetes). Major projects focus on food purchasing patterns, obesity-related health outcomes, and sustainable dietary transitions. He has secured major grants including Academy of Finland funding for the ProScreen trial and EU Horizon grants for LoCard. His interdisciplinary approach bridges statistical innovation with real-world health challenges, emphasizing translational research and data-driven policy recommendations.

Victoria Vickerstaffمشاهده پروفایل

مدرس ارشد

• Medical Statistics
• Clinical Trials
• Epidemiology
• +۵ مورد دیگر

Dr. Victoria Vickerstaff is a Senior Lecturer in Medical Statistics at the Wolfson Institute of Population Health, Queen Mary University of London, and a member of the Centre for Evaluation and Methods within Barts Clinical Trials Unit. She holds an honorary Associate Professor appointment at UCL. Her primary affiliations include Queen Mary’s Wolfson Institute and Barts Clinical Trials Unit, with collaborative roles in the Centre for Psychiatry and Mental Health at QMUL. Her research focuses on medical statistics, clinical trials, and epidemiology across cancer detection, dementia, and mental health. Notable projects include the TRANSFORM prostate cancer screening trial and collaborations on dementia and old-age psychiatry. She has extensive experience in trial design/analysis, contributing to national/international studies in oncology, neurology, and mental health. Her statistical methodologies emphasize multiple outcomes in clinical trials, as seen in her 2019 BMC Methods paper. She serves on clinical trial steering committees and data safety monitoring boards, and contributes to MSc programmes at QMUL. Supervised PhD students include Alice Burnand (delirium management in dementia) and Katie Flanagan (virtual reality in hospice care). Previously, she worked at UCL’s Priment Clinical Trials Unit and the Research Support Service, aiding grant proposals. Her work bridges statistical rigor with clinical impact, particularly in oncology and geriatric care.

• Pharmaceutical Chemistry
• Drug Discovery
• Medicinal Chemistry
• +۶ مورد دیگر

Ana María Cuartero Albesa is an Assistant Professor in the Department of Organic and Pharmaceutical Chemistry at IQS School of Engineering, Universitat Ramon Llull. She is a member of the Grup de Química Farmacèutica (GQF), actively contributing to research in pharmaceutical chemistry and drug development. She also serves as Coordinator of the Bachelor’s Degree in Pharmacy and Technical Director of GMP at IQS Tech Transfer. Research Interests: Her primary research lines include Quality Management in GxP environments—specifically validation of analytical procedures and equipment qualification—and Regulatory Affairs in the Pharmaceutical Industry. Her scholarly work spans drug discovery, particularly in HIV-1 reverse transcriptase inhibition, pharmacokinetics, and biomarker research in oncology. The recent publications show a strong trend in pharmaceutical sciences, focusing on early drug discovery challenges, solid-state properties affecting biological testing, and clinical pharmacology in cancer therapy. Her work bridges academic research with industrial application, particularly in regulated pharmaceutical environments. Scientific Recognition: Active member of the GQF Research Group (2017–2021 and 2022–2025 projects funded by AGAUR). H-index of 3 (Scopus), with publications cited in 23 patents. Advising and Grants: While no direct students are listed, she plays a leadership role in academic programs and research projects. She has participated in two major AGAUR-funded research group grants as a researcher, contributing to collaborative pharmaceutical research. Her work integrates teaching, research, and technology transfer in the pharmaceutical sector. Labs and Teams: She is an integral member of the GQF – Pharmaceutical Chemistry Group, which focuses on new drug development and continuous chemical processes. The group operates within IQS Tech Transfer, emphasizing applied research and industrial collaboration.

Catherine Michauxمشاهده پروفایل

پژوهشگر

• Biophysics
• Structural Biology
• Biochemistry
• +۳ مورد دیگر

Catherine Michaux is a researcher at the Unit of theoretical and structural physico-chemistry at the University of Namur. Her work spans biophysics, structural biology, and computational biology, with a focus on protein interactions, amyloidogenesis, and drug design. She actively participates in international collaborations and leads projects such as PROSTAMET, aiming to improve prostate cancer management through lipid metabolism research. Education : PhD in Chemistry (2004), Master in Chemistry (1999) Her research investigates the structural and functional properties of proteins, including intrinsically disordered proteins and membrane receptors. Recent projects explore metal-dependent aggregation in DPF3 isoforms and the role of environmental factors in amyloid formation. Her publications emphasize interdisciplinary approaches combining biophysical experiments and computational modeling. Recent research trends include studies on QM/MM spectroscopy , zinc finger proteins , and antimitotic strategies . She contributes to datasets on molecular dynamics simulations and crystallography, often collaborating on projects related to protein-ligand interactions and bacterial secretion systems. Michaux supervises multiple research projects funded by institutions like the University of Namur. Key projects include Isothermal Titration Calorimetry for drug design and Investigation of ABC transporters in cancer therapy . Her work also extends to sustainable agriculture via bio-controlled insecticides targeting chitin disruption. Labs/Teams: She is affiliated with the Namur Research Institute for Life Sciences and Namur Institute of Structured Matter , driving interdisciplinary research in physico-chemical approaches to biological systems.

Rumana Omarمشاهده پروفایل

استاد

• Biostatistics
• Medical Statistics
• Risk Prediction Models
• +۷ مورد دیگر

Rumana Omar is a Professor of Medical Statistics at University College London's Department of Statistical Science, leading the Biostatistics Group at the NIHR UCLH/UCL Biomedical Research Centre. She provides statistical leadership for the UCL PRIMENT Clinical Trials Unit and has held prior appointments at Imperial College, London School of Hygiene & Tropical Medicine, and Queen Mary University of London. She holds a PhD in Statistics from the University of Reading (1991). Her research focuses on risk prediction models, missing data methodologies, cluster data analysis, and trials methodology, with applications in cardiology, oncology, dementia, and public health interventions. Her work spans methodological advancements in clinical trial design, cost-effectiveness analyses, and translational research. Notable contributions include developing risk prediction tools for sudden cardiac death in hypertrophic cardiomyopathy patients and evaluating interventions for hearing loss in dementia prevention. Leadership roles: NIHR Rapid Review Sub-Panel (2020), NIHR HTA General Board (2016–2020), MRC Fellowship Panel (2014–2018) Editorial roles: BMC Research Methodology (2016–2019) Awards and honors include elected membership in the International Society for Clinical Biostatistics (2004–2008) and committee roles in the Royal Statistical Society's Medical Section (2014–2019). Her grants and projects include the VALID trial assessing community occupational therapy for dementia carers, the CADMUS imaging trial for prostate cancer, and the LOGIC study on gender identity development in children. Collaborations emphasize interdisciplinary teams across biostatistics, clinical medicine, and public health.

• Medical Decision Making
• Shared Decision Making
• Patient Decision Aids
• +۶ مورد دیگر

Hilary L Bekker is a Professor of Medical Decision Making at the Institute of Health Sciences, School of Medicine, University of Leeds, and holds a dual affiliation with the Research Unit of Patient Involvement Interventions at Aarhus University, Denmark. She leads the Research Centre for Patient Involvement in Central Denmark Region. She has been at the University of Leeds since 2001 and was awarded a personal Chair in 2016. Her educational background includes a BSc (1st Class) in Psychology (1990), MSc in Health Psychology (1994), and PhD in Decision Making and Prenatal Testing (1999). She is a Chartered Psychologist (BPS, 1999) and Fellow of the Higher Education Academy (2004). Hilary’s research focuses on patient and professional healthcare decision-making, shared decision making, and the development of patient decision aids. She integrates methods from decision science, health psychology, and health services research to design and evaluate complex interventions that support informed, collaborative decisions. Her work emphasizes patient involvement, pragmatic research design, and alignment with clinical best practices. Her most recent research outputs include patient decision aids for conditions such as multiple sclerosis, kidney disease, cancer fertility, and chronic diseases, as well as validated questionnaires like SHARED and OPTIQ. These works span digital tools, clinical guidelines, and implementation in primary and specialty care. She has received recognition as a Chartered Psychologist (BPS, 1999) Fellow of the Higher Education Academy (2004) and has contributed to national and international standards through organizations like IPDAS, NICE, and NHS Right Care. Hilary has supervised postgraduate researchers, including Janet Tonge, and has led major educational programs such as the MBChB curriculum at Leeds. She has secured research funding through collaborations and policy partnerships, and her leadership includes roles as Lead for Student Education (LIHS) and Head of Year 1 MBChB. She actively mentors students and leads interdisciplinary teams focused on patient-centered care innovation. She leads the Research Centre for Patient Involvement, which collaborates with health professionals, patients, and methodologists to co-produce decision support tools and training resources, ensuring relevance and impact in real-world healthcare settings.

• Emergency Medicine
• Toxicology
• Echocardiography
• +۳ مورد دیگر

Powell Louis Graham is an Assistant Professor at UMass Chan Medical School in the Department of Emergency Medicine, with additional affiliation in the Division of Toxicology within the T.H. Chan School of Medicine. His clinical and research work spans emergency medicine, toxicology, and echocardiography applications in critical care settings. Education: MD from Central Michigan University, Mt. Pleasant, MI, United States Dr. Graham's research interests have evolved from prostate cancer and oncology (2013-2016) to emergency medicine and critical care applications (2021-2022). His earlier work focused on prostate cancer treatment outcomes, brachytherapy techniques, and health disparities in cancer care. More recently, his research has centered on echocardiography applications in emergency settings, particularly examining image quality, acquisition techniques, and integration with CPR protocols. His work demonstrates a strong focus on practical clinical applications that improve patient care in time-sensitive emergency situations. The publication trends show a clear transition from oncology-focused research to emergency medicine, with his most recent work examining echocardiographic techniques during CPR and brief emergency echocardiography. His research consistently addresses practical clinical challenges with methodologically rigorous approaches. Dr. Graham has collaborated extensively with researchers including Gaspari, Gleeson, Nordberg, and Nalbandian on emergency medicine projects, while his earlier oncology work involved collaborations with Nguyen, Parekh, Aizer, and others. His research has been cited hundreds of times, with his 2013 paper on marital status and cancer survival receiving 447 citations, indicating significant impact in the field. As a faculty member in the Emergency Medicine Department with a focus on Toxicology, Dr. Graham contributes to both clinical care and academic advancement in emergency medicine. His dual expertise in emergency procedures and toxicology positions him to address complex patient presentations requiring specialized knowledge in both areas.

Jean-Baptiste Woillardمشاهده پروفایل

استاد

• Pharmacometrics Modeling
• Artificial Intelligence
• Personalized Medicine
• +۵ مورد دیگر

Jean-Baptiste Woillard is a Professor of Medical Pharmacology at the Faculty of Medicine in Limoges and serves as the head of the "Pharmacometrics and Artificial Intelligence" functional unit within the Department of Pharmacology, Toxicology, and Pharmacovigilance at the University Hospital of Limoges. He also functions as deputy director at Inserm U1248 "Pharmacology & Transplantation" and is actively involved with the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), where he previously served as president of the Pharmacometrics Committee. His professional affiliations include membership in the European Association for Clinical Pharmacology and Therapeutics (EACPT) and the French Society of Pharmacology and Therapeutics (SFPT). Dr. Woillard obtained his PharmD from the University of Toulouse in 2004, followed by a Master's degree in Pharmacology in 2007, and completed his Ph.D. in Pharmacogenetics and Pharmacokinetics in 2011. His academic progression includes positions as Assistant Professor (2010-2014), Associate Professor (2014-2023), and Professor (since 2023) within the Pharmacology, Toxicology Department at the University Hospital of Limoges/INSERM U1248. His research focuses on pharmacometrics modeling, artificial intelligence applications in personalized medicine, and pharmacogenetics. Dr. Woillard's work centers on the personalization of treatments, particularly concerning immunosuppressants in organ transplantation. His research encompasses pharmacogenetic and pharmacodynamic studies, development of pharmacokinetic models, statistical modeling, and the application of machine learning methods to therapeutic drug monitoring. Since 2019, his research has increasingly incorporated AI methodologies to optimize drug dosing and treatment outcomes. Analysis of Dr. Woillard's recent publications reveals a strong emphasis on applying machine learning to pharmacokinetic modeling and therapeutic drug monitoring across various medications including immunosuppressants, antibiotics, and antivirals. His work demonstrates a consistent trajectory toward developing sophisticated algorithms for dose individualization, with particular focus on mycophenolate, tacrolimus, ganciclovir, and daptomycin. The research shows increasing integration of AI techniques with traditional pharmacometric approaches to create more precise dosing strategies. IFCC-Gérard Siest Young Scientist Award (2020) for Distinguished Contributions in Pharmacogenetics Recipient of 1.8 million euros funding through the French PEPR framework for developing multi-scale pharmacological digital twins Dr. Woillard has published over 130 articles in peer-reviewed international scientific journals, delivered more than 30 presentations at national and international conferences, and has been invited to give over 40 academic and industry talks. He leads a significant research consortium focused on developing multi-scale pharmacological digital twins, demonstrating his leadership in securing substantial research funding. His work bridges clinical practice with advanced computational methodologies to improve patient outcomes through personalized medicine approaches. As head of the "Pharmacometrics and Artificial Intelligence" functional unit at the Department of Pharmacology, Toxicology, and Pharmacovigilance (CHU of Limoges), Dr. Woillard directs research efforts focused on treatment personalization, particularly for immunosuppressants in organ transplantation. His team collaborates extensively within the Inserm U1248 unit "Pharmacology & Transplantation," working on both fundamental pharmacological research and clinical applications of their findings. The research group maintains active collaborations with international organizations including the IATDMCT and EACPT.

• Public Health
• Health Disparities
• Latino Health
• +۶ مورد دیگر

Ivette Amelia López, PhD, MPH, is a Professor of Public Health at the University of Utah's Department of Family and Preventive Medicine and serves as Director of the Utah Area Health Education Centers. Originally from Caguas, Puerto Rico, she has dedicated over three decades to advancing health equity for Latino and disadvantaged populations in the United States. Her professional focus spans research, education, and community engagement addressing systemic health disparities. Education PhD from University of South Florida College of Public Health MPH from University of Pittsburgh Graduate School of Public Health BA from Seton Hill University Research Focus Dr. López's research addresses critical public health challenges through interdisciplinary approaches with particular emphasis on: Chronic disease epidemiology (Type 2 diabetes, cardiovascular disease, obesity) Cancer prevention and survivorship in minority populations Social determinants of health and health equity frameworks Community-based participatory research methodologies Cultural humility in healthcare delivery and education Structural barriers in academic medicine and higher education Research Publications Analysis Dr. López's scholarly output demonstrates consistent focus on health disparities across diverse populations. Her recent work examines cardiovascular risks among Hispanic cancer survivors, COVID-19's psychosocial impacts, genetic counseling accessibility, and healthcare policy gaps. Methodologically, she employs mixed-methods approaches with strong community engagement components. Geographic emphasis includes rural communities, HBCU populations, and transnational comparisons (Cameroon, Puerto Rico). Recurrent themes involve cultural competence in intervention design and systemic barriers in healthcare access. Leadership and Community Engagement As Director of Utah AHEC, Dr. López leads initiatives improving healthcare access in underserved communities through educational partnerships and workforce development programs. Her leadership bridges academic research with community health implementation, particularly in Latino populations. She actively mentors emerging health professionals in health equity frameworks.

Esmaeil Nadimiمشاهده پروفایل

استاد

• Artificial Intelligence
• Machine Learning
• Data Science
• +۵ مورد دیگر

Esmaeil Nadimi is a Professor and Head of Unit at The Maersk Mc-Kinney Moller Institute, University of Southern Denmark, where he leads the Applied AI and Data Science research unit. He holds multiple concurrent positions including Visiting Professor at Harvard University, Chair of Data Analytics at SDU eScience Center, and research roles with Innovationsfonden and Swiss National Science Foundation (SNSF) in Medicine & Biology and Health & Well-being domains. His educational background includes a Ph.D. in Electrical and Computer Engineering from Aalborg University (2008) and an M.Sc. in Electrical Engineering (Control Theory) from Sharif University of Technology (2004). Research focuses on foundational AI methodologies including Physics-Infused Learning, Meta & Transfer Learning, with applied research in healthcare (medical imaging, cancer detection, diabetic neuropathy), energy systems, and optical technologies. Core expertise spans machine learning, computer vision, statistical modeling, and medical AI systems development. Publications demonstrate strong emphasis on AI applications in medical diagnostics, particularly capsule endoscopy, cervical/colorectal cancer detection, and diabetic complication screening. Recent work increasingly addresses explainable AI frameworks and practical implementation pathways for clinical adoption. Leadership includes supervision of industrial PhD/postdoc programs and development of academic courses in AI/Data Science. Current grants involve Innovationsfonden and SNSF-funded projects. Leads multiple research teams focused on medical AI systems at SDU Applied AI and Data Science unit.

Chitaru Kuriharaمشاهده پروفایل

استادیار

• Thoracic Surgery
• Lung Transplantation
• Interstitial Lung Disease
• +۶ مورد دیگر

Chitaru Kurihara, MD is an Assistant Professor of Surgery in the Division of Thoracic Surgery at the Feinberg School of Medicine, Northwestern University. He specializes in general thoracic surgery, lung failure management, and lung transplantation, with clinical expertise in interstitial lung disease, COPD, cystic fibrosis, ARDS, and lung cancer. His educational background includes: MD from University of Gunma School of Medicine (2009) Cardiothoracic Residency at University of Tokyo Hospital (2009-2014) Post-doctoral Research Fellowship as Assistant Scientist at University of Wisconsin, Vascular Surgery (2014-2016) Research Associate at Baylor College of Medicine, Cardiothoracic Transplantation (2016-2017) Advanced Lung Failure Fellowship at Northwestern University (2017-2019) Dr. Kurihara's research focuses on advancing lung transplantation techniques for high-risk patients, immunological challenges in transplantation, and multiorgan failure management. His work bridges thoracic surgery, immunology, and oncology to improve outcomes in end-stage lung diseases. His 2025 publications reveal critical trends in transplant surgery: optimizing outcomes for cancer patients undergoing transplantation, overcoming immunological barriers through desensitization protocols, and evaluating pharmacological impacts on recovery. These studies highlight his leadership in solving complex clinical scenarios involving multiorgan failure and high-risk transplant candidates. His honors include: Performed first COVID-19 lung transplant in United States (2020) Winner of resident/fellow research competitions at Northwestern (2018) Top 10 Abstract at American College of Surgeons Clinical Congress (2017) Multiple excellence awards during Japanese surgical training (2013-2014) Dr. Kurihara actively contributes to the International Heart and Lung Transplant Society, American Association for Thoracic Surgery, and Japanese surgical societies. His clinical work integrates with Northwestern's lung transplantation program and NUCATS research initiatives, focusing on translating laboratory insights into improved patient care for complex thoracic conditions.

Ethan Baschمشاهده پروفایل

استاد

• Patient-reported outcomes (PROs)
• Cancer outcomes research
• Comparative effectiveness research
• +۵ مورد دیگر

Ethan Basch, MD, MSc, is the Richard M. Goldberg Distinguished Professor in Medical Oncology at the University of North Carolina at Chapel Hill School of Medicine, Professor of Public Health in the Department of Health Policy and Management at the Gillings School of Global Public Health, and Director of the Cancer Outcomes Research Program at the UNC Lineberger Comprehensive Cancer Center. He also serves as Physician-in-Chief at the North Carolina Basnight Cancer Hospital and is an Associate Editor of the Journal of the American Medical Association (JAMA). Education: BA, Literature, Brown University, 1989 MPhil, Literature, Oxford University, 1991 MD, Medicine, Harvard Medical School, 1998 MSc, Epidemiology, Harvard School of Public Health, 2005 Research Interests: Dr. Basch is a medical oncologist and health services researcher whose work centers on developing and implementing patient-reported outcome (PRO) tools in cancer clinical research and routine care. His clinical expertise is prostate cancer, while his research focuses on patient-reported outcomes, drug regulatory policy, and comparative effectiveness research. He has led the development of the National Cancer Institute’s PRO-CTCAE system for monitoring patient-reported adverse events in clinical trials. Scientific Awards & Honors: 2025 Clinical Innovation Award (UNC Lineberger’s e-PRO initiative) 2024 OncLive Giants of Cancer Care Award 2019 Elected to Board of Directors, American Society of Clinical Oncology (ASCO) 2018 Elected to American Society for Clinical Investigation (ASCI) 2017 Ware/Tarlov Career Achievement Prize in Patient-Reported Outcomes Measures 2012 Appointee, Board of Scientific Advisors, National Cancer Institute 2011 Board of Directors, International Society for Quality of Life Research 2006 Career Development Award, ASCO 2004 Research Investigator Award, Cancer and Leukemia Group B 1989 Fulbright Scholar Leadership & Advisory Roles: Member, Methodology Committee, Patient-Centered Outcomes Research Institute (PCORI) Board of Directors, International Society for Quality of Life Research (ISOQOL) Co-Chair, Health Outcomes Committee, Alliance for Clinical Trials in Oncology Board of Scientific Advisors, National Cancer Institute Principal Investigator, multi-institutional PRO-TECT trial Laboratories & Teams: Dr. Basch leads the Cancer Outcomes Research Program at UNC Lineberger, which recently launched the Patient-Reported Outcomes Center of Excellence. This center fosters interdisciplinary collaboration to advance the science and implementation of PROs in oncology practice across the United States.

Qin Liuمشاهده پروفایل

استاد

• Biostatistics
• Cancer Research
• Immunotherapy
• +۵ مورد دیگر

Qin Liu, Ph.D., M.D., is a Professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute's Ellen and Ronald Caplan Cancer Center. She leads the Biostatistics Unit, providing statistical expertise for translational and pre-clinical cancer research across the institution. Dr. Liu earned her medical degree and master's in health statistics at Shanxi Medical University in China, followed by a Ph.D. in biostatistics from Shanghai Medical University in 1998. She completed a postdoctoral fellowship in biostatistics and epidemiology at the University of Massachusetts, where she also earned a second master's degree in public health and epidemiology. She served as assistant professor in the Department of Cancer Biology at UMMS starting in 2005, then joined the Biostatistical Research Group in 2007. She joined The Wistar Institute in 2011 as an associate professor and was promoted to professor in 2017. Her research applies biostatistics to multiple areas including basic cancer research, clinical trials of cancer immunotherapy, infectious diseases, behavioral and educational intervention research, and health care outcomes. The Biostatistics Unit under her supervision provides statistical support to biological laboratories at The Wistar Institute, including large data management, experiment design, statistical data analysis, and manuscript preparation. Analysis of Dr. Liu's recent publications reveals a strong focus on statistical approaches to complex biological problems, particularly in cancer immunology, HIV research, and biomarker discovery. Her work often involves collaborations across multiple disciplines, combining biostatistical expertise with laboratory and clinical research. Dr. Liu has secured significant funding for collaborative projects, including three NIH P01 Program Project grants on molecular therapies for prostate cancer, melanoma, and EBV-related cancers. Her statistical expertise has contributed to numerous published papers and funded grant proposals for clinical and basic science investigators. The Biostatistics Unit she supervises provides in-house expertise to accommodate the growth in translational cancer research at Wistar. Her team includes scientific programmers and statistical analysts who work closely with laboratory researchers to design experiments and analyze complex biological data.